Question. Are there any results from a previous Phase 1 that would indicate good/great results in the MS pain trail? This could be a minor catalyst for the stock and I believe it will be here before the lawsuit results are announced.
Yes, the STAR PBA trial showed statistically significant relief of pain in the subset of MS patients with PBA who also had neuropathic pain treated with 30 mg dex/ 10 mg quin. compared with patients who got placebo.